URAC Mental Health / Substance Use Disorder Parity Accreditation

The only third-party accreditation program in the United States that validates MHPAEA compliance — and the most consequential behavioral health compliance requirement facing health plans today.

Schedule a Free Discovery Session

Last updated: April 2026

URAC's Mental Health / Substance Use Disorder (MH/SUD) Parity Accreditation is the only accreditation program in the United States specifically designed to validate compliance with the Mental Health Parity and Addiction Equity Act (MHPAEA). It provides health plans, third-party administrators, and managed care organizations with a third-party-validated framework demonstrating that their behavioral health benefits meet or exceed the parity requirements applied to medical and surgical benefits. Integral Healthcare Solutions guides organizations through every phase of this accreditation — from initial gap analysis through committee decision — under the direct leadership of Thomas G. Goddard, JD, PhD, former Chief Operating Officer and General Counsel of URAC.

Governing Law Mental Health Parity and Addiction Equity Act (MHPAEA), 2008; Final Rules September 2024
Who Needs It Health plans, TPAs, and managed care organizations with responsibility for MH/SUD and medical/surgical benefits
Program Status Only program of its kind in the United States
Typical Timeline 12 to 18 months from application to accreditation decision
Accreditation Cycle Two to three years; renewal requires demonstrated ongoing compliance
IHS Consulting Fees Scoped per engagement — contact for proposal

Why MHPAEA Compliance Is the Defining Behavioral Health Compliance Issue of 2025–2026

The Mental Health Parity and Addiction Equity Act was enacted in 2008, but enforcement remained limited for over a decade. That changed with the September 2024 Final Rules, which took effect November 22, 2024, and imposed concrete, enforceable requirements on health plans that many organizations are not yet equipped to meet.

The NQTL Comparative Analysis Requirement

Health plans must conduct documented nonquantitative treatment limitation (NQTL) comparative analyses comparing the processes, strategies, evidentiary standards, and factors used to design MH/SUD benefit limitations against those used for medical/surgical benefits. Initial state-level reviews have found most fully insured plans out of compliance in at least one area.

Named Fiduciary Certification

For plan years beginning on or after January 1, 2025, ERISA plans require a named fiduciary to certify in writing that they engaged in a prudent process to select a qualified service provider to perform and document the NQTL comparative analysis. This creates individual accountability at the executive level.

Network Composition Data

Plans must track and report specific data elements for NQTLs related to network composition — including out-of-network utilization rates, percentage of in-network clinicians actively submitting claims, and time-and-distance standards for behavioral health versus medical/surgical access. Material differences constitute a strong indicator of MHPAEA violation.

Enforcement Escalation

Plans have 10 business days to respond to a government request for comparative analysis documentation and 45 calendar days to demonstrate corrective actions when noncompliance is found. Regulatory fines and parity-related litigation exposure are increasing substantially.

URAC's MH/SUD Parity Accreditation aligns directly with the 2024 Final Rules and provides the operational infrastructure to demonstrate and sustain MHPAEA compliance as enforcement continues to intensify.

Who Should Pursue URAC MH/SUD Parity Accreditation

URAC's MH/SUD Parity Accreditation is available to any organization with comprehensive responsibility for both MH/SUD and medical/surgical benefits. It is particularly relevant for organizations in the following situations:

Health Plans and Issuers

Commercial health insurers, managed care organizations, and Blue Cross Blue Shield plans subject to MHPAEA — particularly those facing state or federal regulatory scrutiny or planning for proactive compliance documentation.

Third-Party Administrators (TPAs)

TPAs administering self-funded employer health plans that include MH/SUD benefits. Purchasers increasingly require parity accreditation as a condition of contract — URAC accreditation provides the validated evidence they require.

Managed Behavioral Health Organizations

MBHOs serving as carved-out behavioral health administrators for health plans, where parity documentation responsibilities are delegated or shared. Accreditation demonstrates the operational framework is in place regardless of administrative structure.

Medicaid Managed Care Organizations

MCOs under state Medicaid contracts who must meet federal MHPAEA requirements and are subject to both CMS oversight and state agency review. Accreditation provides a consistent, documented basis for compliance across multiple regulatory relationships.

Organizations Facing Regulatory Inquiry

Plans that have received state or federal audit findings, litigation threats, or requests for comparative analysis documentation. Accreditation initiates a structured remediation process with documented milestones.

Purchaser-Driven Scenarios

Organizations whose employer or government purchasers are beginning to require parity accreditation as a condition of contract renewal. Proactive accreditation eliminates this as a competitive vulnerability.

How IHS Supports URAC MH/SUD Parity Accreditation

IHS brings a structural advantage that no other consulting firm can match: Thomas G. Goddard, JD, PhD served as Chief Operating Officer and General Counsel of URAC. He knows how URAC reviewers evaluate submissions, where standard interpretations create common deficiencies, and how to structure documentation that holds up under committee review.

01

Standards Gap Analysis

Standard-by-standard review of your current MHPAEA compliance posture against URAC's MH/SUD Parity Accreditation standards. We identify specific documentation gaps, policy deficiencies, operational gaps in NQTL comparative analysis processes, and network composition data shortfalls. Output: a prioritized remediation roadmap with realistic timelines.

02

NQTL Comparative Analysis Development

The NQTL comparative analysis is the technical core of MHPAEA compliance and the area where most plans fall short. IHS develops or reviews your comparative analysis methodology, evaluates the processes, strategies, and evidentiary standards applied to each NQTL, and ensures documentation satisfies both URAC standards and the 2024 Final Rules requirements.

03

Policy and Procedure Architecture

Development of the policy and procedure infrastructure required for accreditation submission — including benefit design policies, network adequacy procedures, utilization management protocols, and appeals and grievance processes that reflect parity-compliant operations. Policies must be operationally active and generating evidence prior to submission.

04

Network Composition Data Framework

Support for designing and implementing the data infrastructure required to track and report on network composition NQTLs — out-of-network utilization, in-network clinician claim submission rates, time-and-distance standards — in a format that supports both URAC accreditation documentation and ongoing regulatory reporting.

05

Application and Submission Management

End-to-end management of the URAC application, documentation compilation, evidence organization, and submission package preparation. IHS manages the desktop review interaction — responding to clarifying questions, providing supplementary documentation, and maintaining submission integrity through the review process.

06

On-Site Review Preparation and Support

Preparation of key personnel for on-site or virtual review interviews, development of document retrieval systems for reviewer requests, and walkthrough of the review agenda. IHS can participate in the on-site review as your consulting representative, providing real-time support through committee decision.

Why IHS for URAC MH/SUD Parity Accreditation

Former URAC Leadership

Thomas G. Goddard, JD, PhD served as URAC's Chief Operating Officer and General Counsel. This is not familiarity with URAC standards — it is authorial knowledge of how the standards were designed and how reviewers apply them.

Unique Program

URAC's MH/SUD Parity Accreditation is the only accreditation of its kind in the United States. Consultants who lack deep URAC relationship history are navigating this program without the institutional context required to do it efficiently.

Legal and Regulatory Depth

MHPAEA compliance sits at the intersection of federal statute, DOL/HHS/Treasury final rules, state parity laws, and ERISA fiduciary requirements. IHS brings both legal and operational expertise — most accreditation consultants bring only one.

28 Accreditation Programs

IHS consults on 28 accreditation and compliance programs under one roof. For organizations pursuing multiple accreditations simultaneously or managing a complex regulatory environment, IHS coordinates the full portfolio rather than optimizing only one program in isolation.

Compliance Program Integration

Parity accreditation does not exist in isolation. IHS integrates MH/SUD Parity Accreditation with your broader compliance program — state mandate tracking, CMS reporting, utilization management standards, and network adequacy requirements — so the accreditation work compounds rather than duplicates compliance investment.

Principal-Led Engagement

Every IHS engagement is led by a principal with subject matter expertise — not delegated to junior staff after the sales process. You have direct access to senior expertise at every phase of the accreditation process.

Start with a Free Discovery Session

A 30-minute conversation with an IHS principal clarifies where your organization stands relative to URAC's MH/SUD Parity Accreditation standards, what a realistic timeline looks like, and what the engagement would involve. No obligation.

Schedule a Free Discovery Session